263 related articles for article (PubMed ID: 32868092)
1. COVID-19: Therapeutics and interventions currently under consideration.
McFee RB
Dis Mon; 2020 Sep; 66(9):101058. PubMed ID: 32868092
[TBL] [Abstract][Full Text] [Related]
2. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control.
Salvamani S; Tan HZ; Thang WJ; Ter HC; Wan MS; Gunasekaran B; Rhodes A
Br J Biomed Sci; 2020 Oct; 77(4):168-184. PubMed ID: 32942955
[TBL] [Abstract][Full Text] [Related]
3. Rationalization of Mushroom-Based Preventive and Therapeutic Approaches to COVID-19: Review.
Rahman MA; Rahman MS; Bashir NMB; Mia R; Hossain A; Saha SK; Kakon AJ; Sarker NC
Int J Med Mushrooms; 2021; 23(5):1-11. PubMed ID: 34347990
[TBL] [Abstract][Full Text] [Related]
4. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19.
Sharma O; Sultan AA; Ding H; Triggle CR
Front Immunol; 2020; 11():585354. PubMed ID: 33163000
[TBL] [Abstract][Full Text] [Related]
5. Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19.
Lu L; Liu X; Jin R; Guan R; Lin R; Qu Z
Biomed Res Int; 2020; 2020():7520746. PubMed ID: 33204713
[TBL] [Abstract][Full Text] [Related]
6. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
Bouayad A
Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
[TBL] [Abstract][Full Text] [Related]
7. A Review of the Current Status of Clinical Management of COVID-19 in the Elderly.
Li Q; Zhao C
Med Sci Monit; 2021 Apr; 27():e930278. PubMed ID: 33833211
[TBL] [Abstract][Full Text] [Related]
8. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
Oliveira SC; de Magalhães MTQ; Homan EJ
Front Immunol; 2020; 11():587615. PubMed ID: 33193414
[TBL] [Abstract][Full Text] [Related]
9. A 21st Century Evil: Immunopathology and New Therapies of COVID-19.
Silva TF; Tomiotto-Pellissier F; Sanfelice RA; Gonçalves MD; da Silva Bortoleti BT; Detoni MB; Rodrigues ACJ; Carloto ACM; Concato VM; Siqueira EDS; Costa IN; Pavanelli WR; Conchon-Costa I; Miranda-Sapla MM
Front Immunol; 2020; 11():562264. PubMed ID: 33193331
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 vaccine development: What lessons can we learn from TB?
Safar HA; Mustafa AS; McHugh TD
Ann Clin Microbiol Antimicrob; 2020 Nov; 19(1):56. PubMed ID: 33256750
[TBL] [Abstract][Full Text] [Related]
11. Novel therapeutic approaches for COVID-19 in chronic kidney disease and transplant.
Ferrey AJ; Hanna R; Reddy UG; Tantisattamo E; Kalantar-Zadeh K; Amin AN
Curr Opin Nephrol Hypertens; 2021 Jan; 30(1):47-53. PubMed ID: 33186223
[TBL] [Abstract][Full Text] [Related]
12. The UK has approved a COVID vaccine - here's what scientists now want to know.
Ledford H; Cyranoski D; Van Noorden R
Nature; 2020 Dec; 588(7837):205-206. PubMed ID: 33288887
[No Abstract] [Full Text] [Related]
13. Why Oxford's positive COVID vaccine results are puzzling scientists.
Callaway E
Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
[No Abstract] [Full Text] [Related]
14. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
Reche PA
Front Immunol; 2020; 11():586984. PubMed ID: 33178220
[TBL] [Abstract][Full Text] [Related]
15. Potential of electric stimulation for the management of COVID-19.
Allawadhi P; Khurana A; Allwadhi S; Navik US; Joshi K; Banothu AK; Bharani KK
Med Hypotheses; 2020 Nov; 144():110259. PubMed ID: 33254561
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study.
Schlesinger T; Weißbrich B; Wedekink F; Notz Q; Herrmann J; Krone M; Sitter M; Schmid B; Kredel M; Stumpner J; Dölken L; Wischhusen J; Kranke P; Meybohm P; Lotz C
PLoS One; 2020; 15(11):e0242917. PubMed ID: 33232382
[TBL] [Abstract][Full Text] [Related]
17. Vaccines After an Emergency Use Authorization (EUA): Modern Evidence Generation Approaches.
Zariffa N; Russek-Cohen E
Ther Innov Regul Sci; 2021 Jul; 55(4):866-871. PubMed ID: 33886112
[TBL] [Abstract][Full Text] [Related]
18. Antibody Therapy: From Diphtheria to Cancer, COVID-19, and Beyond.
Kumar D; Gauthami S; Bayry J; Kaveri SV; Hegde NR
Monoclon Antib Immunodiagn Immunother; 2021 Apr; 40(2):36-49. PubMed ID: 33900819
[TBL] [Abstract][Full Text] [Related]
19. Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity.
Spini A; Giudice V; Brancaleone V; Morgese MG; De Francia S; Filippelli A; Ruggieri A; Ziche M; Ortona E; Cignarella A; Trabace L
Pharmacol Res; 2021 Nov; 173():105848. PubMed ID: 34454035
[TBL] [Abstract][Full Text] [Related]
20. Therapy for Early COVID-19: A Critical Need.
Kim PS; Read SW; Fauci AS
JAMA; 2020 Dec; 324(21):2149-2150. PubMed ID: 33175121
[No Abstract] [Full Text] [Related]
[Next] [New Search]
